Literature DB >> 6702478

The use of depot neuroleptic haloperidol decanoate.

J Fernando, R Krishna Raju, G G Jones, R O Stanley.   

Abstract

Twenty-nine patients were treated with haloperidol decanoate, the dosage ranging from 100 to 300 mg i.m. once a month, with duration of treatment ranging from 3-7 months. It seems that haloperidol decanoate could be useful in schizo-affective disorder/depressed type and also in manic disorder. The investigators were impressed by the relative lack of side effects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6702478     DOI: 10.1111/j.1600-0447.1984.tb02483.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

Review 1.  Depot haloperidol decanoate for schizophrenia.

Authors:  S Quraishi; A David
Journal:  Cochrane Database Syst Rev       Date:  2000

2.  A 15-year open study on a cohort of West-African out-patients with a chronic psychosis.

Authors:  Joop T V M de Jong; I H Komproe
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-09-08       Impact factor: 4.328

Review 3.  Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis.

Authors:  R Beresford; A Ward
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.